P1387: TREATMENT WITH A LEUKEMIA-DERIVED DENDRITIC CELL VACCINE INDUCES INNATE AND ADAPTIVE IMMUNE RESPONSE CORRELATING WITH CLINICAL RESPONSE IN AML PATIENTS IN CR1 WITH MEASURABLE RESIDUAL DISEASE

• Hester van Zeeburg,
• Satwinder Kaur Singh,
• Eva Wagner-Drouet,
• Uwe Platzbecker,
• Tobias Holderried,
• Catharina VAN Elssen,
• Aristoteles Giagounidis,
• Bjorn Tore Gjertsen,
• Arjan van de Loosdrecht,
• Jeroen Rovers

Affiliations

Hester van Zeeburg

1 Mendus AB, Sweden

Satwinder Kaur Singh

1 Mendus AB, Sweden

Eva Wagner-Drouet

2 Universitätsmedizin der Johannes Gutenberg-Universität, Mainz, Germany

Uwe Platzbecker

3 Universitätsklinikum Leipzig, Leipzig, Germany

Tobias Holderried

4 Universiätsklinikum Bonn (UKB), Bonn, Germany

Catharina VAN Elssen

5 Maastricht University Medical Centre, Maastricht, The Netherlands

Aristoteles Giagounidis

6 Marien Hospital Düsseldorf, Dusseldorf, Germany

Bjorn Tore Gjertsen

7 Haukeland Universitetssykehus, Bergen, Norway

Arjan van de Loosdrecht

8 Amsterdam UMC, location VUmc, Department of Hematology, CCA, Amsterdam, The Netherlands

Jeroen Rovers

1 Mendus AB, Sweden